Healthcare Industry News: total hip replacement
News Release - September 22, 2015
Invuity(R) Introduces Eiberg(TM) Illuminated Retractor System With Integrated Intelligent Photonics(TM) To Orthopedic MarketLatest innovation further complements company's portfolio of products designed specifically for use in orthopedic surgeries
SAN FRANCISCO, Sept. 22, 2015 -- (Healthcare Sales & Marketing Network) -- Invuity, Inc. (IVTY), a leading medical technology company, today announced the introduction of its Eiberg™ Illuminated Retractor System. This latest innovation adds to the company's portfolio of orthopedic products including the Saber Yankauer™ Illuminated Aspiration System and Eivector™ Illuminated Retractor System. This product portfolio enables superior intracavity illumination and visualization, supporting the growing trend in orthopedic surgery toward less invasive procedures.
Eiberg™ was designed to address the unmet need for illumination and visualization of the dark surgical cavities encountered by surgeons during total hip replacement surgery and hip and pelvic trauma. The combination of its ergonomic design, atraumatic blade, and integrated Intelligent Photonics™ facilitates simultaneous tissue retraction and broad, volumetric, thermally cool illumination of the surgical target. Additionally, the blade tip design facilitates secure anchoring to bone, ensuring maximum utility during orthopedic procedures.
"With our commitment to advancing the standard of care for surgical interventions, we are pleased to announce the release of Eiberg™, which broadens our orthopedic portfolio," said Invuity CEO Philip Sawyer. "Feedback from surgeons is very positive, and we anticipate a full commercial launch in October as we continue to expand the number of products designed to enable less invasive procedures in orthopedic surgery."
Orthopedic surgeons continue to express to Invuity the need for and value of improved illumination and visualization during procedures such as anterior approach to total hip arthroplasty. Last week, Charles DeCook, M.D., Joint Surgeon Specialists, Northside Hospital, Atlanta, GA, demonstrated and featured the Saber Yankauer™ during an anterior approach total hip replacement surgery that was live-streamed to hundreds of surgeon attendees at the International Congress for Joint Reconstruction (ICJR) Combined OrthoLIVE/MTJR Course.
"Invuity's Intelligent Photonics™ devices offer much needed innovation in less invasive surgical techniques, especially when used in a procedure such as an anterior approach to total hip arthroplasty," said Dr. DeCook. "The Saber Yankauer delivers significantly improved illumination and visualization of the surgical cavity enabling me to perform the procedure with greater precision, efficiency and safety. It has become a standard of care in my clinical practice today and I look forward incorporating Invuity's latest innovations into my surgical armamentarium."
Invuity's Intelligent Photonics™ products will continue to gain broad exposure in orthopedic surgery as they will be showcased at this week's ICJR 4th Annual Anterior Hip Course, a gathering for the world's leading joint replacement surgeons, in Houston, TX (September 24-26).
Invuity, Inc. is a medical technology company focused on developing and marketing advanced photonics devices to improve the ability of surgeons to illuminate and visualize the surgical cavity during open minimally invasive and minimal access surgery. The company's patented Intelligent Photonics™ technology enables enhanced surgical precision, efficiency and safety by providing superior visualization. Clinical applications include breast and thyroid oncology, plastic reconstructive, spine, orthopedic, cardiothoracic and general surgery among others. Invuity is headquartered in San Francisco, CA. For more information, visit www.invuity.com.
This announcement contains forward-looking statements that involve risks and uncertainties, including statements regarding market opportunities and potential results from future new initiatives. Actual results could differ materially from those projected in the forward-looking statements as a result of certain risk factors, including, but not limited to: fluctuations in demand or failure to gain market acceptance for the Company's devices; the Company's ability to demonstrate to and gain approval from hospitals to use the Company's devices; the highly competitive business environment for surgical medical devices; the Company's ability to sell its devices at prices that support its current business strategies; difficulty forecasting future financial performance; protection of the Company's intellectual property; and compliance with necessary regulatory clearances or approvals. The Company undertakes no obligation to update the forward-looking information in this release. More information about potential factors that could affect the Company's business and financial results is included in its filings with the Securities and Exchange Commission, including, without limitation, under the captions: "Management's Discussion and Analysis of Financial Condition and Results of Operations," and "Risk Factors," which are on file with the Securities and Exchange Commission.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.